Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

Impact of Sperm DNA Integrity on ART Treatment

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00875095

Enrollment

Registered

2009-04-03

Start date

2007-10-31

Completion date

2008-12-31

Last updated

2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sperm DNA Impact on ART Outcomes

Keywords

sperm DNA integrity, Toluidine blue staining

Brief summary

The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* needs interventions through artificial reproductive treatment to achieve a pregnancy

Exclusion criteria

* severly oligozoospermic patients

Design outcomes

Primary

Measure	Time frame
Sperm DNA integrity	1 day

Secondary

Measure	Time frame
achievement of a successful pregnancy	1 year

Countries

United States

Outcome results